VBL Therapeutics Announces Peer-reviewed Publication of Positive Results of Pre-specified Interim Analysis of OVAL, a Phase 3 Registration Enabling Study of VB-111 in Ovarian Cancer

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability